Literature DB >> 10501095

Development and reversibility of altered skeletal muscle arteriolar structure and reactivity with high salt diet and reduced renal mass hypertension.

J C Frisbee1, J H Lombard.   

Abstract

OBJECTIVE: To determine the development and reversibility of the altered vasodilator reactivity of cremasteric arterioles in rats on high-salt diet and with reduced renal mass hypertension (RRMHT).
METHODS: Sprague Dawley rats were fed high-salt (HS) or low-salt (LS) diet and RRMHT rats were fed HS diet (HSRRM) over 4 weeks, after which a group of HS and HSRRM rats were fed LS diet for 4 additional weeks (HS/LS and HS/LSRRM), while all others remained on their original diet. Changes in arteriolar diameter to dilator agonists (acetylcholine, iloprost, cholera toxin, forskolin, and sodium nitroprusside) and to Ca2+ free solution plus adenosine (to determine maximum diameter) were measured with a videomicrometer.
RESULTS: Reduced vasodilator reactivity developed over 4 weeks with HS diet and RRMHT, although more rapidly and to a greater extent with RRMHT. In HS rats, the reduced reactivity was completely reversible with restoration of LS diet. Complete recovery of dilator reactivity to control levels did not occur with restoration of LS diet and normotension in HS/LSRRM rats, although the slope of the recovery over the final 4 weeks was comparable to that in normotensive HS/LS animals.
CONCLUSIONS: Impaired vasodilator reactivity, occurring with high-salt diet, appears to be fully reversible. Impaired vascular reactivity may recover after restoration of normal blood pressure in RRMHT, although over a longer period than with high-salt diet alone.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10501095

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  7 in total

1.  Vascular dysfunction precedes hypertension associated with a blood pressure locus on rat chromosome 12.

Authors:  Sasha Z Prisco; Jessica R C Priestley; Brian D Weinberg; Anthony R Prisco; Matthew J Hoffman; Howard J Jacob; Michael J Flister; Julian H Lombard; Jozef Lazar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-08-22       Impact factor: 4.733

2.  Time-course and mechanisms of restored vascular relaxation by reduced salt intake and angiotensin II infusion in rats fed a high-salt diet.

Authors:  Scott T McEwen; James R Schmidt; Lewis Somberg; Lourdes de la Cruz; Julian H Lombard
Journal:  Microcirculation       Date:  2009-02-23       Impact factor: 2.628

3.  High salt diet impairs cerebral blood flow regulation via salt-induced angiotensin II suppression.

Authors:  Linda A Allen; James R Schmidt; Christopher T Thompson; Brian E Carlson; Daniel A Beard; Julian H Lombard
Journal:  Microcirculation       Date:  2019-01-15       Impact factor: 2.628

4.  Genetically hypertensive Brown Norway congenic rat strains suggest intermediate traits underlying genetic hypertension.

Authors:  Marijo Bilusić; Carol Moreno; Nadia E Barreto; Michael R Tschannen; Eugenie L Harris; William K Porteous; Caryn M Thompson; Murray R Grigor; Alan Weder; Eric Boerwinkle; Steven C Hunt; J David Curb; Howard J Jacob; Anne E Kwitek
Journal:  Croat Med J       Date:  2008-10       Impact factor: 1.351

Review 5.  Salt-induced effects on microvascular function: A critical factor in hypertension mediated organ damage.

Authors:  Maria E Marketou; Spyros Maragkoudakis; Ioannis Anastasiou; Helen Nakou; Marina Plataki; Panos E Vardas; Fragiskos I Parthenakis
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-04-19       Impact factor: 3.738

Review 6.  Sodium Intake and Hypertension.

Authors:  Andrea Grillo; Lucia Salvi; Paolo Coruzzi; Paolo Salvi; Gianfranco Parati
Journal:  Nutrients       Date:  2019-08-21       Impact factor: 5.717

7.  Altered potassium ATP channel signaling in mesenteric arteries of old high salt-fed rats.

Authors:  Melissa A Whidden; Bilgen Basgut; Nataliya Kirichenko; Benedek Erdos; Nihal Tümer
Journal:  J Exerc Nutrition Biochem       Date:  2016-06-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.